The Sequential Combination of a JNK Inhibitor and Simvastatin Protects Porcine Islets from Peritransplant Apoptosis and Inflammation

• Published in: Cell transplantation 2011-08, Vol.20 (7), p.1139-1151
• Main Authors: Jin, Sang-Man, Kim, Kang Seok, Lee, Song-Yi, Gong, Chang-Hoon, Park, Su Kyoung, Shin, Jun Seop, Park, Chung-Gyu, Kim, Sang-Joon
• Format: Article
• Language: English
• Subjects: Animals; Anthracenes - pharmacology; Anticholesteremic Agents - pharmacology; Apoptosis - drug effects; Cell Survival; Cells, Cultured; Inflammation Mediators - metabolism; Islets of Langerhans - cytology; Islets of Langerhans - pathology; Islets of Langerhans Transplantation; JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors; JNK Mitogen-Activated Protein Kinases - metabolism; Mice; Mice, Inbred NOD; Niacinamide - pharmacology; Simvastatin - pharmacology; Swine
• ISSN: 0963-6897; 1555-3892
• DOI: 10.3727/096368910X550170

Intraductal administration of a c-Jun NH2-terminal kinase (JNK) inhibitor enhances islet viability. However, its role in reducing the inflammatory response in islets is unknown. It is also unknown whether a JNK inhibitor could act in synergy with statins. We examined if the sequential combination of a JNK inhibitor and simvastatin would reduce islet inflammation and improve islet viability. We performed porcine islet isolation with or without intraductal administration of SP600125, a JNK inhibitor. This was followed by culture medium supplementation with either nicotinamide alone or nicotinamide plus simvastatin. We assessed the viability of islets by flow cytometry, islet loss during overnight culture, graft function in NOD/SCID mice, and expression of inflammation-related genes in islets. The sequential combination of a JNK inhibitor and simvastatin increased the β-cell viability index of porcine islets cultured overnight (p = 0.015) as well as islet viability as assessed by a DNA binding dye staining (p = 0.011). The combination of a JNK inhibitor and simvastatin significantly increased the islet survival rate (p = 0.027) when the histomorphometry of donor pancreas indicated a large islet proportion of greater than 50.55%. When we transplanted the same islet mass per recipient for each group, there was no difference in overall islet graft function. Intraductal administration of JNK inhibitor significantly suppressed mRNA expression levels of interleukin-1β (IL-1β), interferon-γ, tumor necrosis factor-α, IL-6, IL-8, and macrophage chemoattractant protein-1. It also decreased the concentration of IL-1β (p = 0.040) and IL-8 (p = 0.023) in the culture supernatant. In conclusion, the sequential combination of a JNK inhibitor and simvastatin protected porcine islets from peritransplant apoptosis. Inhibition of JNK reduced the inflammatory response and could be considered an alternative target for suppression of porcine islet inflammation.